Exhibit 10.17
** **
AMENDMENT NO. 1 TO THE LAKEWOOD-AMEDEX INC. 2020 EQUITY
INCENTIVE PLAN
This Amendment No. 1 (this “Amendment”) to the Lakewood-Amedex Inc. 2020 Equity Incentive Plan (as amended or amended and restated from time to time, the “Plan”) is adopted by Lakewood-Amedex Biotherapeutics Inc., a Nevada corporation (the “Corporation”), effective as of September 22, 2026 (the “Amendment Effective Date”).
** **
RECITALS
| (A) | The Corporation maintains the Plan, which was adopted by the Board of Directors of the Corporation (the “Board”) on November 30, 2020 and approved by the stockholders of the Corporation on January 25, 2021. |
| (B) | Pursuant to Section 8(a) of the Plan, the Board may amend the Plan at any time, subject to stockholder approval to the extent such approval is necessary under applicable corporate law or Section 1.422-2(b)(2) of the United States Treasury Regulations. |
| (C) | Immediately prior to this Amendment, 183,505 Shares were authorized for issuance under the Plan, as adjusted pursuant to Section 3(d) of the Plan. |
| (D) | On July 20, 2026, the Board approved, subject to stockholder approval, an amendment to the Plan to increase the aggregate number of Shares reserved for issuance under the Plan from 183,505 Shares to 400,000 Shares, an increase of 216,495 Shares. |
| (E) | At the Corporation’s 2026 Annual Meeting of Stockholders held on September 22, 2026, the stockholders of the Corporation approved the amendment to the Plan to increase the number of Shares issuable thereunder to 400,000 Shares. |
NOW, THEREFORE, the Plan is hereby amended as follows:
| 1. | Amendment to Section 3(a). |
Section 3(a) of the Plan is hereby deleted in its entirety and replaced with the following:
“(a) Shares Subject to the Plan. Awards for up to 400,000 Shares shall be available for the grant of Awards under the Plan. The Corporation will reserve for the purposes of the Plan, out of its authorized and unissued Shares, such number of Shares.”
| 2. | Amendment to Section 3(b). |
Section 3(b) of the Plan is hereby deleted in its entirety and replaced with the following:
“(b) Limit on Incentive Stock Options. Notwithstanding any other provisions of this Plan to the contrary, the maximum aggregated number of Shares that will be available for issuance as Incentive Stock Options under this Plan shall be 400,000 Shares.”
Page 1
| 3. | Adjustments. |
The share numbers set forth in this Amendment remain subject to adjustment in accordance with Section 3(d) of the Plan, including in connection with any reverse stock split effected by the Corporation after the Amendment Effective Date.
| 4. | Effectiveness; Ratification. |
This Amendment shall be effective as of the Amendment Effective Date. Except as expressly amended hereby, the Plan remains unchanged and in full force and effect, and references in the Plan to “the Plan” shall mean the Plan as amended by this Amendment.
| 5. | Defined Terms; Governing Law. |
Capitalized terms used but not defined herein have the meanings given to them in the Plan. This Amendment shall be governed by the law that governs the Plan pursuant to Section 13 thereof.
* * *
Page 2
IN WITNESS WHEREOF, the Corporation has caused this Amendment to be executed by its duly authorized officer as of the date first written above.
** **
LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC.
| By: | ||
| Name: | Kelvin Cooper | |
| Title: | Chief Executive Officer | |
| Date: |
Date Amendment approved by Board: July 20, 2026
* *
Date Amendment approved by Stockholders: September 22, 2026
* *
**
Page 3
* *